139 related articles for article (PubMed ID: 3493287)
1. Interleukin 2-activated human lymphocytes exhibit enhanced adhesion to normal vascular endothelial cells and cause their lysis.
Damle NK; Doyle LV; Bender JR; Bradley EC
J Immunol; 1987 Mar; 138(6):1779-85. PubMed ID: 3493287
[TBL] [Abstract][Full Text] [Related]
2. IL-2-activated human killer lymphocytes but not their secreted products mediate increase in albumin flux across cultured endothelial monolayers. Implications for vascular leak syndrome.
Damle NK; Doyle LV
J Immunol; 1989 Apr; 142(8):2660-9. PubMed ID: 2522965
[TBL] [Abstract][Full Text] [Related]
3. Interleukin 2-activated human killer cells are derived from phenotypically heterogeneous precursors.
Damle NK; Doyle LV; Bradley EC
J Immunol; 1986 Nov; 137(9):2814-22. PubMed ID: 2944965
[TBL] [Abstract][Full Text] [Related]
4. IL-2 rapidly induces natural killer cell adhesion to human endothelial cells. A potential mechanism for endothelial injury.
Aronson FR; Libby P; Brandon EP; Janicka MW; Mier JW
J Immunol; 1988 Jul; 141(1):158-63. PubMed ID: 3259966
[TBL] [Abstract][Full Text] [Related]
5. Activated endothelial cells resist lymphokine-activated killer cell-mediated injury. Possible role of induced cytokines in limiting capillary leak during IL-2 therapy.
Mier JW; Brandon EP; Libby P; Janicka MW; Aronson FR
J Immunol; 1989 Oct; 143(7):2407-14. PubMed ID: 2528594
[TBL] [Abstract][Full Text] [Related]
6. Limiting dilution analysis of the frequency of human T cells and large granular lymphocytes proliferating in response to interleukin 2. I. The effect of lectin on the proliferative frequency and cytotoxic activity of cultured lymphoid cells.
Vose BM; Bonnard GD
J Immunol; 1983 Feb; 130(2):687-93. PubMed ID: 6600251
[TBL] [Abstract][Full Text] [Related]
7. Lysis of human T cell leukemia virus infected T and B lymphoid cells by interleukin 2-activated killer cells.
Froelich CJ; Guiffaut S
J Immunol; 1987 Dec; 139(11):3637-43. PubMed ID: 2824611
[TBL] [Abstract][Full Text] [Related]
8. Lymphokine-activated killer cells: lysis of fresh syngeneic natural killer-resistant murine tumor cells by lymphocytes cultured in interleukin 2.
Rosenstein M; Yron I; Kaufmann Y; Rosenberg SA
Cancer Res; 1984 May; 44(5):1946-53. PubMed ID: 6608989
[TBL] [Abstract][Full Text] [Related]
9. Rapid generation of potent and tumor-specific cytotoxic T lymphocytes by interleukin 18 using dendritic cells and natural killer cells.
Tanaka F; Hashimoto W; Okamura H; Robbins PD; Lotze MT; Tahara H
Cancer Res; 2000 Sep; 60(17):4838-44. PubMed ID: 10987295
[TBL] [Abstract][Full Text] [Related]
10. rIL 2-induced proliferation of human circulating NK cells and T lymphocytes: synergistic effects of IL 1 and IL 2.
Ben Aribia MH; Leroy E; Lantz O; Métivier D; Autran B; Charpentier B; Hercend T; Senik A
J Immunol; 1987 Jul; 139(2):443-51. PubMed ID: 3110271
[TBL] [Abstract][Full Text] [Related]
11. Ability of human T lymphocytes to adhere to vascular endothelial cells and to augment endothelial permeability to macromolecules is linked to their state of post-thymic maturation.
Damle NK; Doyle LV
J Immunol; 1990 Feb; 144(4):1233-40. PubMed ID: 1968077
[TBL] [Abstract][Full Text] [Related]
12. Alteration of human lymphokine-activated killer cell activity by manipulation of protein kinase C and cytosolic Ca2+.
McCrady CW; Li F; Grant AJ; Merchant RE; Carchman RA
Cancer Res; 1988 Feb; 48(3):635-40. PubMed ID: 3257170
[TBL] [Abstract][Full Text] [Related]
13. VLA-6 (CDw49f) is an important adhesion molecule in NK cell-mediated cytotoxicity following autologous or allogeneic bone marrow transplantation.
Lowdell MW; Shamim F; Hamon M; Macdonald ID; Prentice HG
Exp Hematol; 1995 Dec; 23(14):1530-4. PubMed ID: 8542943
[TBL] [Abstract][Full Text] [Related]
14. Interleukin 15 induction of lymphokine-activated killer cell function against autologous tumor cells in melanoma patient lymphocytes by a CD18-dependent, perforin-related mechanism.
Gamero AM; Ussery D; Reintgen DS; Puleo CA; Djeu JY
Cancer Res; 1995 Nov; 55(21):4988-94. PubMed ID: 7585540
[TBL] [Abstract][Full Text] [Related]
15. Human NK cells can lyse porcine endothelial cells independent of their expression of Galalpha(1,3)-Gal and killing is enhanced by activation of either effector or target cells.
Horvath-Arcidiacono JA; Porter CM; Bloom ET
Xenotransplantation; 2006 Jul; 13(4):318-27. PubMed ID: 16768725
[TBL] [Abstract][Full Text] [Related]
16. IL-4 inhibits IL-2 induction of LAK cytotoxicity in lymphocytes from a variety of lymphoid tissues.
Colquhoun SD; Economou JS; Shau H; Golub SH
J Surg Res; 1993 Nov; 55(5):486-92. PubMed ID: 8231167
[TBL] [Abstract][Full Text] [Related]
17. Mechanism of cell-mediated cytotoxicity at the single cell level. VI. Direct assessment of the cytotoxic potential of human peripheral blood non-lytic effector-target cell conjugates.
Bonavida B; Lebow LT; Bradley TP
J Immunol; 1984 Feb; 132(2):594-8. PubMed ID: 6606675
[TBL] [Abstract][Full Text] [Related]
18. Interleukin 1 increases the binding of human B and T lymphocytes to endothelial cell monolayers.
Cavender DE; Haskard DO; Joseph B; Ziff M
J Immunol; 1986 Jan; 136(1):203-7. PubMed ID: 3079607
[TBL] [Abstract][Full Text] [Related]
19. Antibody-dependent cellular cytotoxicity mediated by murine lymphocytes activated in recombinant interleukin 2.
Shiloni E; Eisenthal A; Sachs D; Rosenberg SA
J Immunol; 1987 Mar; 138(6):1992-8. PubMed ID: 3493293
[TBL] [Abstract][Full Text] [Related]
20. Lymphocyte adhesion and transendothelial migration in the central nervous system: the role of LFA-1, ICAM-1, VLA-4 and VCAM-1. off.
Greenwood J; Wang Y; Calder VL
Immunology; 1995 Nov; 86(3):408-15. PubMed ID: 8550078
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
